APrf Renly Lim
Senior Research Fellow
School of Pharmacy and Biomedical Sciences
College of Health
Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.
Associate Professor Renly Lim is an internationally recognised leader in pharmacy and medicine safety. She is the Clinical Practice Research Lead at the Quality Use of Medicines and Pharmacy Research Centre at the Adelaide University, where she leads innovative, policy-relevant research aimed at improving clinical practice and reducing medicine-related harm. She is also an adjunct fellow at IMU University, Malaysia.
After completing her PhD at Universiti Sains Malaysia, Renly undertook postdoctoral research with the Mahidol Oxford Tropical Medicine Research Unit. During this time, she led a community engagement program supporting malaria elimination in Cambodia. The program was featured in The Lancet and received the University of Oxford Public Engagement with Research Award, as well as the Vice-Chancellor’s Choice Award in 2019.
Since moving to Australia, she has established a nationally influential research program in pharmacy and medicine safety, including work that directly informed the Australian health ministers’ decision to declare Quality Use of Medicines and Medicines Safety as the 10th National Health Priority Area. She has secured $15 million in competitive funding to support her research and has produced more than 100 outputs, including peer-reviewed publications, reports for the Australian Government, the Wellcome Trust, and the World Health Organization.
Renly also holds international leadership roles in pharmacy. She served as President of the International Pharmaceutical Federation (FIP) Young Pharmacists Group (2021-22), leading a global team of 45 pharmacists and pharmaceutical scientists from 21 countries. FIP is the peak global pharmacy body, representing over 5.5 million pharmacists and pharmaceutical scientists worldwide. In 2023, she was appointed to the FIP Policy Committee on Access to Medicines, contributing to the development of a global policy statement to improve access to medicines, which was endorsed by the FIP Council in 2024 and adopted by 158 national pharmacy organisations across 108 countries. As a Board member of the FIP Data and Intelligence Commission (2023-current), she contributes to data-driven initiatives aimed at transforming pharmacy practice and advancing global workforce reform.
A Digitally Enabled, Pharmacist service to detecT medicine harms in residential aged care: the ADEPT project (Lead Investigator; Funded by Aged Care Research & Industry Innovation Australia (ARIIA))
Co-designing a consumer-focused digital health system to improve adverse drug event (ADE) detection, management and reporting (CIA; NHMRC Ideas Grant GNT2020626)
Medicines Advice Initiative Australia (MAIA) – supporting quality use of medicines (Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program Health Professional Education Grant Program)
| Date | Position | Institution name |
|---|---|---|
| 2026 - ongoing | Associate Professor | Adelaide University |
| 2025 - ongoing | Adjunct Fellow | IMU University |
| 2023 - 2025 | Senior Research Fellow | University of South Australia |
| 2016 - 2022 | Research Fellow | University of South Australia |
| 2016 - 2016 | Postdoctoral Fellow | Mahidol Oxford Tropical Medicine Research Unit |
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2023 | Award | MICRE Best research translation presentation award | Medicines Intelligence Centre of Research Excellence (MI-CRE) Annual Research Symposium and Policy Forum | Australia | - |
| 2022 | Award | SA Tall Poppy | Australian Institute of Policy and Science | Australia | - |
| 2021 | Award | UniSA Early Career Researcher Award | University of South Australia | Australia | - |
| 2021 | Award | UniSA Best Early Career Researcher presentation award | University of South Australia | Australia | - |
| 2020 | Award | PSA Early Career Pharmacist Award | Pharmaceutical Society of Australia SA/NT | Australia | - |
| 2019 | Award | Best Poster Award | International Pharmaceutical Federation Social and Administrative Pharmacy Section | Netherlands | - |
| 2019 | Award | Vice Chancellor’s Public Engagement with Research Award | University of Oxford | United Kingdom | - |
| 2019 | Award | Vice Chancellor’s Choice Award for Public Engagement with Research | University of Oxford | United Kingdom | - |
| 2019 | Recognition | SA’s most powerful women in Science, Medicine, Innovation and Space | The Advertiser | Australia | - |
| 2018 | Award | Winnovation Award | Women in Innovation | Australia | - |
| 2018 | Award | South Australia Fresh Scientist | Science in Public | Australia | - |
| 2016 | Award | Clinical Research Prize | QRS International | Germany | - |
| 2016 | Award | Asia's Top 10 best paper | Urological Association of Asia (UAA) Congress | Singapore | - |
| 2016 | Award | Best oral presentation | Malaysian Urological Conference | Malaysia | - |
| 2010 | Recognition | Dean’s Merit List | University of Strathclyde | United Kingdom | - |
| Language | Competency |
|---|---|
| Chinese (Cantonese) | Can speak and understand spoken |
| Chinese (Mandarin) | Can speak and understand spoken |
| English | Can read, write, speak and understand spoken |
| Malay | Can read, write, speak and understand spoken |
| Year | Citation |
|---|---|
| 2025 | Ho, J. N., Pratt, N., Hillen, J., Nassar, N., Zoega, H., Lim, R., & Daniels, B. (2025). Uptake and Use of Biologic Medicines in Paediatric Immune-Mediated Inflammatory Diseases: An Australian Population-Based Study. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 34 (pp. 272). WILEY. |
| 2025 | Dedefo, M. G., Kassie, G. M., Gebreyohannes, E. A., Lim, R., Roughead, E., & Ellett, L. K. (2025). Completeness of Spontaneously Reported Adverse Drug Reactions in Four Developed Countries. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 34 (pp. 521). WILEY. |
| 2025 | Mekuria, A. B., Andrade, A. Q., Rowett, D., Lim, R., Hedstrom, M., & Roughead, E. (2025). Evaluating the Responsiveness and Interpretability of a Tool for Measuring Changes in Potential Medicine-Related Symptoms Overtime. In DRUG SAFETY Vol. 48 (pp. 1 page). ADIS INT LTD. |
| 2025 | Mekuria, A. B., Andrade, A. Q., Rowett, D., Lim, R., Hedstrom, M., & Roughead, E. E. (2025). Evaluation of Potential Medicine-Related Symptom Burden and Health-Related Quality of Life Among Patients Using Regular Medicines: A Cross-Sectional Study. In DRUG SAFETY Vol. 48 (pp. 2 pages). ADIS INT LTD. |
| 2024 | Gebreyohannes, E. A., Thornton, C., Thiessen, M., Coombs, G., Hwang, I., de Vries, S. T., & Lim, R. (2024). Views on The Development and Use of a New Digital Health Platform to Improve Adverse Drug Event Detection, Management and Reporting in Australia: A Qualitative Study. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 33 (pp. 309). WILEY. |
| 2023 | Lim, R., Hoh, W., & Ramos, D. (2023). Nurses' Opinions on a Geriatric Care Bundle Intervention: An Experience from a Singapore Community Hospital. In JOURNAL OF THE AMERICAN GERIATRICS SOCIETY Vol. 71 (pp. S36). CA: WILEY. |
| 2021 | Mushafi, A. A., Lim, R., Le, A. C., Holdsworth, S., & Odobasic, D. (2021). HUMAN AMNIOTIC EPITHELIAL STEM CELLS ATTENUATE CRESCENTIC GLOMERULONEPHRITIS. In NEPHROLOGY Vol. 26 (pp. 35). WILEY. |
| 2019 | Lim, R., Roughead, E. E., Ramsay, E., Moffat, A., & Pratt, N. (2019). PERSISTENCE WITH OPIOIDS POST DISCHARGE FROM HOSPITALISATION FOR SURGERY IN AN AUSTRALIAN ADULT COHORT. In RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY Vol. 15 (pp. E14). ELSEVIER SCIENCE INC. |
| 2018 | Crosthwaite, A., Lim, R., Masterson, R., Velcoska, E., Hedley, A., Burrell, L., . . . Ierino, F. (2018). PROFILING CARDIAC BIOMARKERS PREDICTS CARDIAC PATHOPHYSIOLOGY IN URAEMIC CARDIOMYOPATHY. In NEPHROLOGY Vol. 23 (pp. 46). WILEY. |
| 2017 | Tripura, R., Lim, R., Peto, T. J., Sareth, M., Sanann, N., Pell, C., . . . Cheah, P. Y. (2017). PUBLIC ENGAGEMENT WITH SCIENCE: A COMMUNITY DRAMA PROJECT AGAINST MALARIA IN CAMBODIA. In AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE Vol. 97 (pp. 160). MD, Baltimore: AMER SOC TROP MED & HYGIENE. |
| 2017 | Lim, R., Liong, M. L., Leong, W. S., & Yuen, K. H. (2017). Association between male and female sexual function in couples with stress urinary incontinence partners. In BJU INTERNATIONAL Vol. 119 (pp. 6). SINGAPORE, Singapore: WILEY. |
| 2017 | Lim, R., Liong, M. L., Leong, W. S., & Yuen, K. H. (2017). Effect of pulsed magnetic stimulation on quality of life of patients with stress urinary incontinence. In BJU INTERNATIONAL Vol. 119 (pp. 7). SINGAPORE, Singapore: WILEY. |
| 2016 | Lim, R., Yuen, K. H., Nurzalina, A. K. K., Leong, W. S., & Liong, M. L. (2016). Initial, mid-term and durable response of pulsed magnetic stimulation for female stress urinary incontinence. In INTERNATIONAL JOURNAL OF UROLOGY Vol. 23 (pp. 25). WILEY-BLACKWELL. |
| 2016 | Lim, R., Liong, M. L., Leong, W. S., Khan, N. A. K., & Yuen, K. H. (2016). EFFECT OF PULSED MAGNETIC STIMULATION ON SEXUAL FUNCTION IN COUPLES WITH INCONTINENT PARTNERS. In JOURNAL OF UROLOGY Vol. 195 (pp. E334). CA, San Diego: ELSEVIER SCIENCE INC. DOI |
| 2015 | Lim, R., Liong, M. L., Leong, W. S., Khan, N. A. K., & Yuen, K. H. (2015). Pulsed magnetic stimulation for stress urinary incontinence: a randomized, sham-controlled study. In BJU INTERNATIONAL Vol. 116 (pp. 3). MALAYSIA: WILEY-BLACKWELL. WoS2 |
| 2015 | Lim, R., Liong, M. L., Khan, N. A. K., & Yuen, K. H. (2015). VALIDITY AND RELIABILITY OF THE GOLOMBOK RUST INVENTORY OF SEXUAL SATISFACTION (GRISS) IN PATIENTS WITH STRESS URINARY INCONTINENCE. In JOURNAL OF SEXUAL MEDICINE Vol. 12 (pp. 352-353). WILEY-BLACKWELL. WoS1 |
| 2015 | Lim, R., Liong, M. L., Khan, N. A. K., & Yuen, K. H. (2015). THE IMPACT OF STRESS URINARY INCONTINENCE ON SEXUAL FUNCTION IN A MALAYSIAN POPULATION. In JOURNAL OF SEXUAL MEDICINE Vol. 12 (pp. 332). WILEY-BLACKWELL. |
| Year | Citation |
|---|---|
| 2026 | Boord, M. S., Brown, P., Soriano, J., Meola, T. R., Dumuid, D., Milte, R., . . . Lim, R. (2026). A Digitally-Enabled, Pharmacist service to detecT medicine harms in residential aged care (ADEPT): A feasibility study. (Preprint). DOI |
| 2024 | Gebreyohannes, E. A., Thornton, C., Thiessen, M., de Vries, S. T., Q Andrade, A., Kalisch Ellett, L., . . . Lim, R. (2024). Co-Designing a Consumer-Focused Digital Reporting Health Platform to Improve Adverse Medicine Event Reporting: Protocol for a Multimethod Research Project (the ReMedi Project) (Preprint). DOI |
| 2022 | Lim, R., Thornton, C., Stanek, J., Ellett, L. K., & Thiessen, M. (2022). Development of a web-based system to report medication-related adverse effects: a design and usability study (Preprint). DOI |
A/Prof Renly Lim has secured $15 million in research funding as Chief Investigator and $5 million as Associate Investigator. Recent projects include:
- Evaluating long-term effectiveness using real world evidence of highly specialised treatments – Cancer (EVEREST-C), MRFF Incorporating Patient Data in Health Technology Assessment Decision Making, $2 million, 2026-2029
- National Multidisciplinary Primary Care Research, Policy and Advocacy
Consortium, MRFF Multidisciplinary Models of Primary Care, $5.2 million, 2025-2029 (Associate Investigator) - Co-designing a consumer-focused digital health system to improve adverse drug event (ADE) detection, management and reporting, NHMRC Ideas grant, $1.7 million, 2023-2026
- Medication Safety series, Pharmaceutical Society of Australia, 2018 - 2026
- Medicines Advice Initiative Australia (MAIA) – supporting quality use of medicines, Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program Health Professional Education Grant Program, Australian Government Department of Health, Disability and Ageing, $5.8 million, 2023-2025
- A Digitally Enabled, Pharmacist service to detecT medicine harms in residential aged care: the ADEPT project, Aged Care Research & Industry Innovation Australia, $351k, 2023-2024
- Improving the safety of implantable medical devices, NHMRC - Ideas Grants, $775k, 2021-2024
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2024 | Co-Supervisor | The Application of Artificial Intelligence for Adverse Drug Event Support: Language models-Driven Approach | - | Doctorate | Full Time | Mr Mulugeta Kalayou |
| 2022 | Co-Supervisor | Identifying and addressing evidence gaps in post-market risk management of biologic medicines: priorities for pharmacovigilance in Australia | - | Doctorate | Full Time | Miss Jun Ho |
| 2022 | Co-Supervisor | Evaluation of patient-reported outcome measures for longitudinal monitoring of medicine-related harm. | - | Doctorate | Full Time | Mr Abebe Basazn Mekuria |
| Date | Role | Board name | Institution name | Country |
|---|---|---|---|---|
| 2023 - ongoing | Board Member | FIP Data and Intelligence Commission | International Pharmaceutical Federation (FIP) | Netherlands |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2023 - ongoing | Member | FIP Policy committee on Access to Medicines | International Pharmaceutical Federation (FIP) | Netherlands |
| 2021 - 2022 | President | Young Pharmacists’ Group | International Pharmaceutical Federation (FIP) | Netherlands |
| 2020 - ongoing | Member | FIP Policy committee on Patient Safety | International Pharmaceutical Federation (FIP) | Netherlands |
| Date | Role | Editorial Board Name | Institution | Country |
|---|---|---|---|---|
| 2026 - ongoing | Associate Editor | Pharmacy Education | International Pharmaceutical Federation | Netherlands |
| 2026 - ongoing | Consulting Editor | BMC Digital Health | BioMed Central | United Kingdom |
Available For Media Comment.